Table of Content

1. Executive Summary
1.1. Global Small Molecule CMO/CDMO Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Small Molecule CMO/CDMO Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Small Molecule CMO/CDMO Market Outlook: Product
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
3.3.3.1. Standard API
3.3.3.2. HPAPI
3.4. Market Attractiveness Analysis: Product
3.5. Global Small Molecule CMO/CDMO Market Outlook: Service
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Service, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
3.5.3.1. Process Development
3.5.3.2. Analytical Method Development
3.5.3.3. GMP Manufacturing Service
3.5.3.4. Scale-Up and Tech Transfer
3.5.3.5. Quality Control and Quality Assurance
3.5.3.6. Regulatory Assistance
3.5.3.7. Technology and Innovation
3.6. Market Attractiveness Analysis: Service
3.7. Global Small Molecule CMO/CDMO Market Outlook: Company Size
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Company Size, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
3.7.3.1. Large
3.7.3.2. Mid-sized
3.7.3.3. Small
3.8. Market Attractiveness Analysis: Company Size
3.9. Global Small Molecule CMO/CDMO Market Outlook: Scale of Operation
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Scale of Operation, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
3.9.3.1. Clinical
3.9.3.2. Phase I
3.9.3.3. Phase II
3.9.3.4. Phase III
3.9.3.5. Commercial
3.10. Market Attractiveness Analysis: Scale of Operation
4. Global Small Molecule CMO/CDMO Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia & Pacific
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Product
5.3.3. By Service
5.3.4. By Company Size
5.3.5. By Scale of Operation
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
5.5.1. Standard API
5.5.2. HPAPI
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
5.6.1. Process Development
5.6.2. Analytical Method Development
5.6.3. GMP Manufacturing Service
5.6.4. Scale-Up and Tech Transfer
5.6.5. Quality Control and Quality Assurance
5.6.6. Regulatory Assistance
5.6.7. Technology and Innovation
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
5.7.1. Large
5.7.2. Mid-sized
5.7.3. Small
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
5.8.1. Clinical
5.8.2. Phase I
5.8.3. Phase II
5.8.4. Phase III
5.8.5. Commercial
5.9. Market Attractiveness Analysis
6. Europe Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Product
6.3.3. By Service
6.3.4. By Company Size
6.3.5. By Scale of Operation
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Turkey
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
6.5.1. Standard API
6.5.2. HPAPI
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
6.6.1. Process Development
6.6.2. Analytical Method Development
6.6.3. GMP Manufacturing Service
6.6.4. Scale-Up and Tech Transfer
6.6.5. Quality Control and Quality Assurance
6.6.6. Regulatory Assistance
6.6.7. Technology and Innovation
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
6.7.1. Large
6.7.2. Mid-sized
6.7.3. Small
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
6.8.1. Clinical
6.8.2. Phase I
6.8.3. Phase II
6.8.4. Phase III
6.8.5. Commercial
6.9. Market Attractiveness Analysis
7. East Asia Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Product
7.3.3. By Service
7.3.4. By Company Size
7.3.5. By Scale of Operation
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
7.5.1. Standard API
7.5.2. HPAPI
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
7.6.1. Process Development
7.6.2. Analytical Method Development
7.6.3. GMP Manufacturing Service
7.6.4. Scale-Up and Tech Transfer
7.6.5. Quality Control and Quality Assurance
7.6.6. Regulatory Assistance
7.6.7. Technology and Innovation
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
7.7.1. Large
7.7.2. Mid-sized
7.7.3. Small
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
7.8.1. Clinical
7.8.2. Phase I
7.8.3. Phase II
7.8.4. Phase III
7.8.5. Commercial
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Product
8.3.3. By Service
8.3.4. By Company Size
8.3.5. By Scale of Operation
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
8.5.1. Standard API
8.5.2. HPAPI
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
8.6.1. Process Development
8.6.2. Analytical Method Development
8.6.3. GMP Manufacturing Service
8.6.4. Scale-Up and Tech Transfer
8.6.5. Quality Control and Quality Assurance
8.6.6. Regulatory Assistance
8.6.7. Technology and Innovation
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
8.7.1. Large
8.7.2. Mid-sized
8.7.3. Small
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
8.8.1. Clinical
8.8.2. Phase I
8.8.3. Phase II
8.8.4. Phase III
8.8.5. Commercial
8.9. Market Attractiveness Analysis
9. Latin America Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Product
9.3.3. By Service
9.3.4. By Company Size
9.3.5. By Scale of Operation
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
9.5.1. Standard API
9.5.2. HPAPI
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
9.6.1. Process Development
9.6.2. Analytical Method Development
9.6.3. GMP Manufacturing Service
9.6.4. Scale-Up and Tech Transfer
9.6.5. Quality Control and Quality Assurance
9.6.6. Regulatory Assistance
9.6.7. Technology and Innovation
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
9.7.1. Large
9.7.2. Mid-sized
9.7.3. Small
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
9.8.1. Clinical
9.8.2. Phase I
9.8.3. Phase II
9.8.4. Phase III
9.8.5. Commercial
9.9. Market Attractiveness Analysis
10. Middle East & Africa Small Molecule CMO/CDMO Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Product
10.3.3. By Service
10.3.4. By Company Size
10.3.5. By Scale of Operation
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
10.5.1. Standard API
10.5.2. HPAPI
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service, 2023 - 2030
10.6.1. Process Development
10.6.2. Analytical Method Development
10.6.3. GMP Manufacturing Service
10.6.4. Scale-Up and Tech Transfer
10.6.5. Quality Control and Quality Assurance
10.6.6. Regulatory Assistance
10.6.7. Technology and Innovation
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Company Size, 2023 - 2030
10.7.1. Large
10.7.2. Mid-sized
10.7.3. Small
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Scale of Operation, 2023 - 2030
10.8.1. Clinical
10.8.2. Phase I
10.8.3. Phase II
10.8.4. Phase III
10.8.5. Commercial
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition HPAPI
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Pfizer CentreOne
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Baxter BioPharma Solutions
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Catalent
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Lonza
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Syngene International
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Boehringer Ingelheim
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Piramal Pharma Solutions
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Wuxi AppTec
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Patheon (Thermo Fisher Scientific Inc.)
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Adare Pharma Solutions
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Ajinomoto Bio-Pharma Services
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations